One attractive additional player is the phospholipid-remodeling enzyme Lpcat3, which we have recently shown affects inflammatory signaling in hepatocytes in the setting of obesity (Rong et al., 2013). The gene discussed is LPCAT3; the disease is obesity due to melanocortin 4 receptor deficiency.